Κατάλογος ενδεικτικών δημοσιεύσεων του τμήματος Ιατρικής ΑΠΘ σε διεθνή επιστημονικά περιοδικά κατά τα τελευταία 5 έτη.
Iron chelation therapy of transfusion-dependent β-thalassemia during pregnancy in the era of novel drugs: is deferasirox toxic?.
Int J Hematol. 103(5), 537-44.
(2016).
(2016). Is there a role for low-dose eltrombopag as maintenance therapy in the treatment of immune thrombocytopenia?.
Acta Haematol. 133(1), 78-82.
(2015). Laboratory investigation of platelet function in patients with thalassaemia..
Acta Haematol. 132(1), 45-8.
(2014). Combination therapy for mucormycosis: why, what, and how?.
Clin Infect Dis. 54 Suppl 1, S73-8.
(2012). Safety of deferasirox in sickle cell disease patients with co-existing liver impairment..
Br J Haematol. 157(4), 505-6; author reply 506-7.
(2012). Is deferasirox implicated in multiple organ failure in a patient with homozygous β-thalassemia?.
Angiology. 62(4), 346-8.
(2011).
(2010).
Telmisartan for prevention of cardiovascular events..
N Engl J Med. 360(3), 302; author reply 303.
(2009).